Abstract
found in this condition. [1] Data from recent studies have suggested that some patients with SS carry inhibitory autoantibodies directed against muscarinic acetylcholine receptors especially M3 muscarinic acetylcholine receptor (M3R 
Materials and Methods
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Study population
Serum samples were collected from 42 Japanese patients with SS (15 with primary SS and 27 with secondary SS) who had been followed up at the Division of Rheumatology, University of Tsukuba Hospital, Ibaraki, Japan. All patients with SS satisfied the Japanese Ministry of Health criteria for the diagnosis of SS.
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These criteria included four clinicopathological findings: lymphocytic infiltration of the salivary or lacrimal glands, dysfunction of salivary secretion, keratoconjunctivitis sicca, and presence of anti-SS-A or SS-B antibodies. The diagnosis of SS was based on the presence of two or more of the above items.
We also recruited 42 healthy controls (HC). Approval for this study was obtained 90 from the local ethics committee and a signed informed consent was obtained from each subject.
Synthesis of peptide antigens
We synthesized different peptides encoding the extracellular domains of 95 human-M3R. The N-terminal of human-M3R has a 66-mer amino acid sequence, and accordingly we divided this domain into three segments. The sequences were, MTLHNNSTTSPLFPNISSSWIHSPSDAGLP for N-terminal 1, IHSPSDAGLPPGTVTHFGSYNVSRAAGNFS for N-terminal 2, and NVSRAAGNFSSPDGTTDDPLGGHTVWQV for N-terminal 3 (Sigma-Aldrich 100 Japan, Ishikari, Japan). These three peptides were mixed and used for the peptide antigens of the N-terminal region. We also synthesized three peptides corresponding to the sequences of the three extracellular loops of human-M3R, VLVNTFCDSCIPKTFWNLGY for the third (Sigma-Aldrich Japan). As a control peptide, we synthesized a peptide corresponding to the sequences of the third extracellular loop of human-M5 muscarinic acetylcholine receptor (M5R), whose sequences were STFCDKCVPVTLWH (Sigma-Aldrich Japan). As a negative peptide, we also synthesized a 25 mer peptide whose sequence was 110 SGSGSGSGSGSGSGSGSGSGSGSGS (Sigma-Aldrich Japan).
Enzyme-linked immunosorbent assay (ELISA)
Peptide solution (100 µl/well at 10 µg/ml) in 0. 
Measurement of salivary secretion
We assessed salivary secretion by the Gum test. In this test, the volume of saliva is measured after chewing gum for 10 min.
Histopathological examination
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Histopathological findings of the labial salivary glands were classified according to Greenspan grading. [7] Expression of M3R mRNA in HSG cells ]i in HC. [2] 170
Statistical analysis
Differences between groups were examined for statistical significance using the Mann-Whitney's U-test, while differences in frequencies were analyzed by the Fisher's exact probability test. A P value less than 0.05 denoted the presence of a statistically significant difference. 
Results
Anti-M3R antibodies in patients with SS and control subjects
The average age of SS patients was 53.1 ± 13.2 y, that of HC was 33.1 ± 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Correlation between anti-M3R antibodies and various clinicopathological
220 features Disease duration of SS was shorter among anti-M3R antibodies-positive SS (7.3 ± 7.6 y) than -negative SS (15.5 ± 11.1 y, p<0.05, Mann-Whitney's U-test).
The positivity for anti-SS-A antibody and the IgG value in serum was more prevalent and higher among anti-M3R antibodies-positive SS than -negative SS antibodies-positive and -negative SS (Table 2 ). There is no significant 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 determined in the present study was much higher than that reported in our previous study (11%). [4] The reason for this difference is probably related to the change in the methodology, such as increased sensitivity resulting from purity of the synthetic peptides, modification of the washing procedure, or other factors introduced in the modified ELISA system.
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In the present study, we also determined the precise B cell epitopes of M3R molecules. B cell epitopes in the present study are areas including peptides recognized by anti-M3R antibodies, although we do not know that these linear peptides are really conformational epitopes or not. However, we showed anti-M3R antibodies against these linear epitopes exactly influenced Ca influx 290 via M3R in HSG cells. Therefore, we suggest that these linear peptides might consist of the conformational epitopes on the M3R. Several B cell epitopes were identified on the extracellular domains, and some SS patients were reactive to several extracellular domains other than the second extracellular loop. The second extracellular loop of M3R has been the focus of our interest in epitopes 295 and function of anti-M3R antibodies. [4, 5, 9 , 10] Recently, Koo et al. [6] reported that the third extracellular loop represents a functional epitope bound by SS-IgG.
In contrast to these results, we found in the present study that antibodies to the second extracellular loop of M3R inhibited the increase of [Ca 2+ ]i induced by cevimeline hydrochloride in a functional assay using HSG cells. This inhibitory 300 effect of anti-M3R antibodies might explain the reduction in salivary secretion in some SS patients. Our data also demonstrated that antibodies against the third on the secretion of saliva could be different from these epitopes, although further experiments using antibodies from more patients are necessary.
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